Overview

A Phase Study to Evaluate the Efficacy and Safety of YZJ-4729 in Patients With Moderate to Severe Acute Pain After Abdominal Surgery

Status:
ACTIVE_NOT_RECRUITING

Trial end date:
2024-11-01

Target enrollment:

Participant gender:

Summary

Primary Objective To explore the analgesic efficacy of YZJ-4729 compared with placebo in patients with acute postoperative pain following abdominal surgery. Secondary Objective To explore the analgesic efficacy and safety of YZJ-4729 compared with placebo and morphine in patients with acute postoperative pain following abdominal surgery.

Phase:

PHASE2

Details

Lead Sponsor:

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

Treatments:

Morphine